Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS).
DrugDrug NameDrug Indication
DB00008Peginterferon alfa-2aPeginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies. Peginterferon alfa-2a is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation [FDA Label].
DB00022Peginterferon alfa-2bPeginterferon alfa-2b is indicated for the treatment of HCV in combination with [DB00811] and a NS3/4A protease inhibitor for genotype 1 or without a NS3/4A protease inhibitor for genotypes 2-6 [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.
DB00059PegaspargaseFor treatment of acute lymphoblastic leukemia
DB00375ColestipolColestipol is indicated as adjunctive therapy to diet for the reduction of elevated serum total and low-density lipoprotein cholesterol (LDL-C) in patients with primary hypercholesterolemia (a condition that features elevated LDL-C) who do not respond adequately to diet [FDA Label, L6115, F4555]. Therapy with lipid-altering agents like colestipol should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia [FDA Label, L6115, F4555]. Treatment should begin and continue with dietary therapy [FDA Label, L6115, F4555]. In general, a minimum of six months of intensive dietary therapy and counseling should be carried out prior to initiation of drug therapy such as that with colestipol [FDA Label, F4555]. Shorter periods may be considered in patients with severe elevations of LDL-C or with definite coronary heart disease [FDA Label, F4555]. Although colestipol is effective in all types of hypercholesterolemia, some regional prescribing information note in particular that it is medically most appropriate in patients with Fredrickson's type II hyperlipoproteinemia [L6115]. Nevertheless, in patients with combined hypercholesterolemia and hypertriglyceridemia, although colestipol may be helpful in reducing elevated cholesterol, it is not formally indicated where hypertriglyceridemia is the abnormality of greatest concern [F4567].
DB00638InulinHistorically used in an important medical test of renal function, specifically a measure of glomerular filtration rate. Sometimes used to help relieve symptoms of diabetes mellitus - a condition characterised by hyperglycemia and/or hyperinsulinemia.
DB00702IcodextrinUsed for continuous ambulatory peritoneal dialysis (CAPD) of diabetic patients or automated peritoneal dialysis (APD) for the management of end-stage renal disease.
DB00840Hydroxypropyl celluloseUsed to relieve dryness and irritation caused by reduced tear flow that occurs in certain eye diseases (keratoconjunctivitis sicca), recurrent corneal erosions, decreased corneal sensitivity, exposure and neuroparalytic keratitis, and as a lubricant for artificial eyes.
DB00893Iron DextranFor treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.
DB00908QuinidineFor the treatment of ventricular pre-excitation and cardiac dysrhythmias
DB01344TolevamerUsed to treat abnormally high potassium levels.
DB01432CholestyramineIndicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Also for the relief of pruritus associated with partial biliary obstruction.
DB02061CellobioseNot Available
DB02237MaltotetraoseNot Available
DB02430Trehalose-6-PhosphateNot Available
DB02717CellotetraoseNot Available
DB03323MaltoseNot Available
DB04682Octylphenoxy polyethoxyethanolNot Available
DB04941CrofelemerFor the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy.
DB04978SP1049CIntended for the treatment of carcinoma of the oesophagus.
DB05321PEG-uricaseInvestigated for use/treatment in hyperuricemia.
DB05384Carbopol 974PInvestigated for use/treatment in contraception and HIV prevention.
DB05446LJP 1082Investigated for use/treatment in autoimmune diseases, strokes, and thrombosis.
DB05718Maxy-G34Investigated for use/treatment in adverse effects (chemotherapy) and neutropenics.
DB05899IT-101Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
DB06206SugammadexSugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery.
DB06423EndostatinInvestigated for use/treatment in cancer/tumors (unspecified), macular degeneration, and diabetic retinopathy.
DB06439TyloxapolTyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus. Tyloxapol is administered either through nebulized solution or a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications.
DB06611PegsunerceptInvestigated for use/treatment in rheumatoid arthritis.
DB06776Sodium cellulose phosphateNot Available
DB06804Nonoxynol-9Nonoxynol 9 is a surfactant spermicide used for contraception in spermicidal creams, jellies, foams, gel, and lubricants. It is also used in conjuction with other methods of contraception, including condoms, cervical caps and diaphragms.
DB06811PolidocanolPolidocanol is a sclerosing agent indicated to treat uncomplicated spider veins and uncomplicated reticular veins in the lower extremity.
DB06812Povidone-iodineFor topical application in the treatment and prevention of infection in wounds.
DB08894PeginesatidePeginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis
DB08904Certolizumab pegolCertolizumab pegol has been approved for several different conditions listed below: - Symptomatic management of Chron's disease patients and for the maintenance of clinical response in patients with moderate to severe disease with inadequate response to conventional therapy. - Treatment of adult patients with moderate to severely active rheumatoid arthritis. - Treatment of adult patients with active psoriatic arthritis. - Treatment of adult patients with active ankylosing spondylitis. - Treatment of adult patients with moderate-to-severe plaque psoriasis that are candidates for systemic therapy or phototherapy.[FDA label] - Treatment of adult patients with active non-radiographic axial spondyloarthritis with objective signs of inflammation.[L5819] In Canada, certolizumab pegol is additionally approved in combination with [methotrexate] for the symptomatic treatment, including major clinical response, and for the reduction of joint damage in adult patients with moderately to severely active rheumatoid arthritis and psoriatic arthritis.[L5825] Inflammation is a biological response against a potential threat. This response can be normal but in certain conditions, the immune system can attack the body's normal cells or tissues which causes an abnormal inflammation.[L5840] TNF-alpha has been identified as a key regulator of the inflammatory response. The signaling cascades of this inflammatory mediator can produce a wide range of reactions including cell death, survival, differentiation, proliferation and migration.[A176660]
DB08917Ferric carboxymaltoseFerric carboxymaltose is a iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron or those who have non-dialysis dependent chronic kidney disease.
DB09049NaloxegolIndicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
DB09106Hydroxyethyl StarchAn intravenous solution of hydroxyethyl starch is used to prevent shock following severe blood loss caused by trauma, surgery, or other issues.
DB09107Methoxy polyethylene glycol-epoetin betaFor the treatment of patients with anaemia associated with chronic kidney disease. Not a substitute for RBC transfusion if immediate correction of anemia is required.
DB09111PentastarchThe primary intended use of pentastarch is as a substitute for older colloids such as albumin or hetastarch for use in plasma volume expansion.
DB09122Peginterferon beta-1aFor the treatment of patients with relapsing forms of multiple sclerosis.
DB09208PegloticaseFor the treatment of chronic gout in adult patients refractory to conventional therapy.
DB09255DextranDextran is used as the restoration of blood mass during surgical interventions if there is hypovolemia due to trauma or dehydration. It is as well used after the presence of hemorrhage in cases of blood loss to a level inferior to 15% of the blood mass, if compatibility test cannot be completed or when blood lots need to be tested for pathogen detection. Dextran is also used for the prevention of profound postoperative venous thrombosis.[L1455] Dextran as well presents ophthalmic applications as solutions or ointments for the temporary relief of xerophthalmia or minor ocular irritations.[L1461]
DB09287Polyethylene glycolUsed to treat and prevent constipation.
DB09311PolycarbophilPolycarbophil is used to treat constipation and to help maintain regular bowel movements.
DB09372Tannic acidTannic acid is indicated for cold sores, fever blisters, diaper rash, minor burn or sunburn and prickly heat. Vaginally, tannic acid is used as a douche for leukorrhea. It has been also indicated for sore throat, inflamed tonsils, spongy or receding gums, and acute dermatitis.
DB09507FerumoxsilNot Available
DB09508FerumoxidesNot Available
DB09512Simethicone1. To relieve pain and discomfort caused by excess gas in the intestine and stomach in cases such as flatulence and post operative gaseous distention. 2. It could be used also prior to an endoscopy to eliminate foam, gas and air from the gastrointestinal tract to reduce gas shadow which will result in better visualization.
DB10535Karaya gumNot Available
DB10667TragacanthNot Available
DB10852CarobNot Available
DB11059CarboxymethylcelluloseIndicated for the symptomatic relief of burning, irritation and discomfort of the eyes due to dryness or exposure to wind or sun.
DB11060Polyvinyl alcoholFor use as a lubricant to prevent further irritation or to relieve dryness of the eye(s) [L2828].
DB11061PovidoneWhen in complex with iodine, indicated for inducing antisepsis for prevention of infection in minor cuts, scrapes, and burns.
DB11063Polysorbate 80It is used as a solubilizer, antimicrobial preservative and disinfectant [L1853].
DB11074DimethiconeDimethicone is a colorless liquid with both cosmetic and therapeutic uses. It is used in topical creams and ointments to help distribute the active ingredients. Dimethicone is used as an anti-foaming agent, a hair and skin conditioner, and in the treatment of head lice and, as an anti-bloating/anti-flatulence agent [L1765], [L1772].
DB11075HypromelloseProtectant (ophthalmic) [L1805] Tears (artificial) [L1805] Lubricant (ophthalmic) [L1805] Diagnostic aid (contact lens procedures; gonioscopy) [L1805]
DB11077Polyethylene glycol 400PEG-400 has been indicated for the temporary relief of burning and irritation due to dryness of the eye, and for protection against further irritation and desiccation [L1795], [L1796], [L1797].
DB11120TurpentineTurpentine has been used experimentally in a bath for the treatment of disseminated sclerosis and sexual dysfunction. It also has been studied for its antibacterial activity and inhibition of osteoclast activity. Turpentine is utilized in experimental models of inflammation to induce a systemic inflammatory immune response in animals.
DB11158PectinPectin is used in food as a gelling agent and stabilizer. As a medical drug, it has obtained a great interest in its potential use as a source of dietary fiber, lipid, cholesterol, serum glucose and insulin level lowering effect, gastric emptying delay.[A32327] Some recent studies have researched the possibility of using pectin for the formation of nanoparticles as a delivery vehicle of drugs.[A32331]
DB11161Polyethylene glycol 300Indicated as a lubricant in over-the-counter ophthalmic solutions to temporarily relieve redness, burning and irritation of the eyes.
DB11165RosinNot Available
DB11178Polysorbate 20Not Available
DB11223Tolu balsamNot Available
DB11228MethylcelluloseSolutions containing methyl cellulose are used as substitute for tears or saliva if the natural production of these fluids is disturbed. It is also used or constipation, diverticulosis, hemorrhoids and irritable bowel syndrome. Used in the manufacture of capsules in nutritional supplements. Its edible and nontoxic properties provide a vegetarian alternative to the use of gelatin.
DB11234PoliglusamNot Available
DB11252Poloxamer 407Not Available
DB11333Poloxamer 188Indicated to reduce viscosity in the blood before transfusions.
DB11417GleptoferronNot Available
DB11451PoloxaleneNot Available
DB11482Balsam of PeruBalsam of Peru is found in diverse cosmetics and perfumes as well as a flavoring agent in cough syrups, lozenges, chewing gum, and candies.[F117] As a medical agent, balsam of Peru is used in the local treatment of burns and wounds as an antiseptic.[A27160] It is also used as an expectorant, heart stimulant to increase blood pressure and as a parasiticide.[T221]
DB11567Insulin peglisproNot Available
DB11585Drometrizole trisiloxaneDrometrizole trisiloxane is used as an active ingredient in various sunscreens for the indication of protecting the skin by absorbing the damaging UV radiation of sunlight [A33069, L2780, L2781, L2782, L2783, F81, F82].
DB11599Starch, cornNot Available
DB11602Hydroxyethyl celluloseFor alleviating surface irritation in topical ocular administrations, such as artificial tear solutions. Hydroxyethyl cellulose is also found in topical formulations to aid in more efficient drug diffusion across the membranes.
DB11635TocofersolanTocofersolan is indicated in vitamin E deficiency caused by digestive malabsorption in pediatric patients with congenital chronic cholestasis or hereditary chronic cholestasis from birth (full term newborns) up to 18 years of age [L2371].
DB11854AstodrimerNot Available
DB120402-octyl cyanoacrylateNot Available
DB12310TrehaloseNot Available
DB12358EnbucrilateNot Available
DB12521Methyl pyrrolidoneNot Available
DB12842PegamotecanNot Available
DB13128SizofiranNot Available
DB13446Guar gumNot Available
DB13477Sodium apolateNot Available
DB13480LentinanNot Available
DB13560DextranomerNot Available
DB13570Oxidized celluloseNot Available
DB13933Nonacog beta pegolNonacog beta pegol is indicated for the use in adults and children with hemophilia B for control and prevention of bleeding episodes, routine prophylaxis and perioperative management.[L1100] In the EMA approval, it is also indicated for on-demand treatment of bleeding episodes.[L1099] Hemophilia B is characterized by a deficiency in the coagulation factor IX which results in prolonged oozing after injuries and delayed or recurring bleeding prior wound healing. Hemophilia B patients present more frequent bleeding episodes during childhood and adolescence than in adulthood.[T56]
DB14091Carbomer homopolymer type CNot Available
DB14124CyclomethiconeNot Available
DB14139Hydroxyethyl ethylcelluloseNot Available
DB14158Microcrystalline celluloseNot Available
DB14326AmberNot Available
DB09329Antihemophilic Factor (Recombinant), PEGylatedFor the management of hemophilia A (congenital factor VIII deficiency) [FDA label], [A32064]. This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older) with hemophilia A (congenital factor VIII deficiency). It is also used for on-demand treatment and control of bleeding and routine prophylaxis of bleeding episodes. It is not indicated for the treatment of von Willebrand disease [FDA label].
DB14684Calcium polycarbophilPolycarbophil is used to treat constipation and to help maintain regular bowel movements.
DB02078TriglymeNot Available
DB02327Triethylene glycolNot Available
DB03995BetadexNot Available
DB14730Calaspargase pegolThis drug is is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years [FDA label]. The pharmacokinetics of calaspargase pegol were examined when given in combination with multiagent chemotherapy in 124 patients with B-cell lineage ALL [L4890]. The FDA approval of this drug was based on the achievement and maintenance of nadir serum asparaginase activity above the level of 0.1 U/mL when administering calaspargase, 2500 U/m2 intravenously, at 3-week intervals.
DB06592PegargiminaseInvestigated for use/treatment in melanoma and hepatocellular carcinoma.
DB11313Phenyl trimethiconeNot Available
DB06496Dextrin 2-sulfateInvestigated for use/treatment in HIV prevention.
DB14767Peginterferon lambda-1aNot Available
DB14771Polyacrylamide (crosslinked; 2 mole percent bisacrylamide)Not Available
DB14832PolydioxanoneNot Available
DB14836PolydextroseNot Available
DB14927AmylopectinNot Available
DB14951Etirinotecan pegolNot Available
DB14953Firtecan pegolNot Available
DB15112Somatropin pegolNot Available
DB15216AmyloseNot Available
DB15379Hydroxypropyl betadexNot Available
DB15441Lulizumab pegolNot Available
DrugDrug NameTargetType
DB00008Peginterferon alfa-2aInterferon alpha/beta receptor 2target
DB00008Peginterferon alfa-2aInterferon alpha/beta receptor 1target
DB00008Peginterferon alfa-2aCytochrome P450 1A2enzyme
DB00022Peginterferon alfa-2bInterferon alpha/beta receptor 1target
DB00022Peginterferon alfa-2bInterferon alpha/beta receptor 2target
DB00022Peginterferon alfa-2bCytochrome P450 1A2enzyme
DB00022Peginterferon alfa-2bCytochrome P450 2D6enzyme
DB00022Peginterferon alfa-2bCytochrome P450 2C9enzyme
DB00059PegaspargaseL-asparaginetarget
DB00059PegaspargaseThyroxine-binding globulincarrier
DB00375ColestipolBile acidstarget
DB00638InulinCycloinulo-oligosaccharide fructanotransferasetarget
DB00702IcodextrinPancreatic alpha-amylaseenzyme
DB00893Iron DextranHemoglobin subunit betatarget
DB00893Iron DextranHemoglobin subunit alphatarget
DB00893Iron DextranFerritin heavy chaintarget
DB00893Iron DextranFerritin light chaintarget
DB00893Iron DextranSerotransferrincarrier
DB00908QuinidineSodium channel protein type 5 subunit alphatarget
DB00908QuinidineAlpha-1-acid glycoprotein 1carrier
DB00908QuinidinePotassium voltage-gated channel subfamily H member 2target
DB00908QuinidinePotassium channel subfamily K member 1target
DB00908QuinidinePotassium channel subfamily K member 6target
DB00908QuinidineCytochrome P450 1A2enzyme
DB00908QuinidineCytochrome P450 2E1enzyme
DB00908QuinidineCytochrome P450 1A1enzyme
DB00908QuinidineCytochrome P450 2D6enzyme
DB00908QuinidineCytochrome P450 3A4enzyme
DB00908QuinidineCytochrome P450 3A7enzyme
DB00908QuinidineSolute carrier family 22 member 2transporter
DB00908QuinidineSolute carrier family 22 member 1transporter
DB00908QuinidineSolute carrier family 22 member 5transporter
DB00908QuinidineMultidrug resistance protein 1transporter
DB00908QuinidineSolute carrier organic anion transporter family member 1A2transporter
DB00908QuinidineSolute carrier family 22 member 8transporter
DB00908QuinidineCanalicular multispecific organic anion transporter 1transporter
DB00908QuinidineSolute carrier family 22 member 4transporter
DB00908QuinidineSolute carrier organic anion transporter family member 1B1transporter
DB00908QuinidineCytochrome P450 2B6enzyme
DB00908QuinidineCytochrome P450 2C9enzyme
DB00908QuinidineAlpha-1A adrenergic receptortarget
DB00908QuinidineAlpha-1B adrenergic receptortarget
DB00908QuinidineAlpha-1D adrenergic receptortarget
DB00908QuinidineBile salt export pumptransporter
DB00908QuinidineCytochrome P450 2C8enzyme
DB01344TolevamerPotassiumtarget
DB01432CholestyramineBile acidstarget
DB02061CellobioseEndoglucanase Gtarget
DB02061CellobioseEndoglucanase 5Atarget
DB02061CellobioseEndoglucanasetarget
DB02237MaltotetraoseGlucan 1,4-alpha-maltotetraohydrolasetarget
DB02237MaltotetraoseNeopullulanase 2target
DB02430Trehalose-6-PhosphateHTH-type transcriptional regulator TreRtarget
DB02717CellotetraoseCellulose 1,4-beta-cellobiosidasetarget
DB03323MaltoseCyclomaltodextrin glucanotransferasetarget
DB03323MaltoseAlpha-amylase 2Btarget
DB03323MaltoseBeta-amylasetarget
DB03323MaltoseMaltogenic alpha-amylasetarget
DB03323MaltoseMaltodextrin phosphorylasetarget
DB03323MaltoseMaltose-binding periplasmic proteintarget
DB03323MaltoseAlpha-glucosidasetarget
DB03323MaltoseMaltose binding proteintarget
DB03323MaltoseMalto-oligosyltrehalose trehalohydrolasetarget
DB04682Octylphenoxy polyethoxyethanolTroponin C, skeletal muscletarget
DB04941CrofelemerCystic fibrosis transmembrane conductance regulatortarget
DB04941CrofelemerAnoctamin-1target
DB04978SP1049CDNA topoisomerase 2-alphatarget
DB05321PEG-uricaseUric acid degradation bifunctional proteintarget
DB05446LJP 1082Beta-2-glycoprotein 1target
DB06423Endostatin72 kDa type IV collagenasetarget
DB06423EndostatinMatrix metalloproteinase-9target
DB06423EndostatinCollagenase 3target
DB06423EndostatinFocal adhesion kinase 1target
DB06423EndostatinE-selectintarget
DB06423EndostatinCytochrome P450 19A1enzyme
DB06439TyloxapolLipoprotein lipasetarget
DB06776Sodium cellulose phosphateCalcium ionstarget
DB06804Nonoxynol-9Prostaglandin G/H synthase 2enzyme
DB08894PeginesatideErythropoietin receptortarget
DB08904Certolizumab pegolTumor necrosis factortarget
DB08904Certolizumab pegolAlcohol dehydrogenase [NADP(+)]enzyme
DB09049NaloxegolCytochrome P450 3A4enzyme
DB09049NaloxegolCytochrome P450 2D6enzyme
DB09049NaloxegolCytochrome P450 2C19enzyme
DB09049NaloxegolMu-type opioid receptortarget
DB09107Methoxy polyethylene glycol-epoetin betaErythropoietin receptortarget
DB09208PegloticaseUric acidtarget
DB11059CarboxymethylcelluloseSolute carrier family 2, facilitated glucose transporter member 1target
DB11075HypromelloseEpithelial cell adhesion moleculetarget
DB11077Polyethylene glycol 400Oxidoreductase HTATIP2target
DB11077Polyethylene glycol 400Cytochrome P450 4A11enzyme
DB11077Polyethylene glycol 400Alcohol dehydrogenase class-3enzyme
DB11077Polyethylene glycol 400Sulfotransferase 1A1enzyme
DB11077Polyethylene glycol 400Ectonucleotide pyrophosphatase/phosphodiesterase family member 1target
DB11120TurpentineMitogen-activated protein kinase 1target
DB11635TocofersolanMultidrug resistance protein 1target
DB11635TocofersolanLeukotriene-B(4) omega-hydroxylase 1enzyme
DB11635TocofersolanAlpha-tocopherol transfer proteintransporter
DB11635TocofersolanScavenger receptor class B member 1transporter
DB11635TocofersolanNiemann-Pick C1-like protein 1transporter
DB11635TocofersolanATP-binding cassette sub-family G member 5transporter
DB11635TocofersolanATP-binding cassette sub-family G member 8transporter
DB11635TocofersolanATP-binding cassette sub-family A member 1transporter
DB11635TocofersolanSEC14-like protein 4transporter
DB11635TocofersolanSEC14-like protein 2transporter
DB11635TocofersolanSEC14-like protein 3transporter
DB11635TocofersolanApolipoprotein B receptortransporter
DB11635TocofersolanCytochrome P450 3A4enzyme
DB11854AstodrimerEnvelope glycoprotein gp160target
DB13933Nonacog beta pegolCoagulation factor VIItarget
DB13933Nonacog beta pegolCoagulation factor VIIItarget
DB13933Nonacog beta pegolCoagulation factor Xtarget
DB09329Antihemophilic Factor (Recombinant), PEGylatedvon Willebrand factortarget
DB09329Antihemophilic Factor (Recombinant), PEGylatedvon Willebrand factorcarrier
DB02078TriglymeOuter-membrane lipoprotein LolBtarget
DB02078TriglymeProfilin-2target
DB02078TriglymeOuter-membrane lipoprotein LolBtarget
DB02078TriglymeUncharacterized proteintarget
DB02078TriglymeSerine acetyltransferasetarget
DB02078TriglymeTyrosine-protein kinase Fyntarget
DB02078TriglymePeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
DB02078TriglymeTranscriptional regulator, GntR familytarget
DB02078TriglymeABC transporter, periplasmic substrate-binding proteintarget
DB02078TriglymeTransketolasetarget
DB02327Triethylene glycolAcetolactate synthase, catabolictarget
DB02327Triethylene glycolArabinogalactan endo-1,4-beta-galactosidasetarget
DB02327Triethylene glycolPhosphoserine aminotransferasetarget
DB03995BetadexNeopullulanase 2target
DB03995BetadexMaltose-binding periplasmic proteintarget
DB03995BetadexMaltogenic amylasetarget
DB14730Calaspargase pegolL-asparaginetarget